The role of IL-13 and NK T cells in experimental and human ulcerative colitis

Mucosal Immunology

Volumn 1, Issue , 2008, Pages 31-33

  Fuss, I J ^a   Strober, W ^a  

^a NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 13;

CROHN DISEASE; ENTERITIS; EXPERIMENTATION; HUMAN; IMMUNOPATHOLOGY; NATURAL KILLER T CELL; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; REVIEW; TH1 CELL; ULCERATIVE COLITIS;

ANIMALS; COLITIS, ULCERATIVE; HUMANS; INTERLEUKIN-13; NATURAL KILLER T-CELLS; OXAZOLONE;

EID: 54349118972     PISSN: 19330219     EISSN: 19353456     Source Type: Journal    
DOI: 10.1038/mi.2008.40     Document Type: Review

References (12)

1. Fuss, I. J. et al. Disparate CD4+ lamina propria (LP) lymphokines secretion profiles in inflammatory bowel disease. Crohn’s disease LP cells manifest increased secretion of IFN-γ, whereas ulcerative colitis LP cells manifest increased secretion of IL-5. J. Immunol. 153, 1261-1270 (1996).
2. Boirivant, M., Fuss, I. J., Chu, A. & Strober, W. Oxazalone colitis: a murine model of T helper cell type 2 colitis treatable with antibodies to inteleukin 4. J. Exp. Med. 188, 1929-1939 (1998).
3. Heller, F., Fuss, I. J., Niewenhuis, E. E., Blumberg, R. S. & Strober, W. Oxazalone colitis, a Th2 colitis model resembling ulcerative colitis, is mediated by IL-13-producing NK-T cells. Immunity 17, 629-638 (2002).
4. Kronenberg, M. & Gapin, L. The unconventional lifestyle of NKT cells. Nat. Rev. Immunol. 2, 557-568 (2002).
5. Brigl, M. & Brenner, M. B. CD1: antigen presentation and T cell function. Annu. Rev. Immunol. 22, 817-890 (2004).
6. Baron, J. L., Gardiner, L., Nishimura, S. & Shinkai, K. Activation of a nonclassic NKT cell subset in a transgenic mouse model of hepatitis B virus infection. Immunity 16, 583-594 (2002).
7. Dao, T., Mehal, W. Z. & Crispe, I. N. IL-18 augments perforin-dependent cytotoxicity of liver NK-T cells. J. Immunol. 161, 2217-2222 (1998).
8. Brutkiewicz, R. R., Bennink, J. R., Yewdell, J. W. & Bendelac, A. TAP-independent beta 2-microglobulin-dependent surface expression of functional mouse CD1.1. J. Exp. Med. 182, 1913-1919 (1995).
9. van de Wal, Y. et al. Delineation of a CD1d-restricted antigen presentation pathway associated with human and mouse intestinal epithelial cells. Gastroenterology 124, 1420-1431 (2003).
10. Heller, F. et al. Interleukin-13 is the key effector Th2 cytokine in ulcerative colitis that affects epithelial tight junctions, apoptosis, and cell restitution. Gastroenterology 129, 550-564 (2005).
11. Fuss, I. J. et al. Nonclassical CD1d-restricted NK T cells that produce IL-13 characterize an atypical Th2 response in ulcerative colitis. J. Clin. Invest. 113, 1490-1497 (2004).
12. Fichtner-Feigl, S., Strober, W., Kawakami, K., Puri, R. K. & Kitani, A. IL-13 signaling through the IL-13 α 2 receptor is involved in induction of TGF-β 1 production and fibrosis. Nat. Med. 12, 99-106 (2006).